Compare REPL & ATLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | REPL | ATLC |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | N/A | 576 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 692.8M | 797.4M |
| IPO Year | 2018 | N/A |
| Metric | REPL | ATLC |
|---|---|---|
| Price | $1.79 | $66.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | $11.00 | ★ $90.00 |
| AVG Volume (30 Days) | ★ 2.4M | 53.5K |
| Earning Date | 05-21-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $477.21 |
| Revenue Next Year | N/A | $10.42 |
| P/E Ratio | ★ N/A | $9.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.68 | $45.74 |
| 52 Week High | $13.24 | $78.91 |
| Indicator | REPL | ATLC |
|---|---|---|
| Relative Strength Index (RSI) | 19.65 | 73.16 |
| Support Level | N/A | $64.75 |
| Resistance Level | $8.82 | $70.95 |
| Average True Range (ATR) | 0.83 | 2.80 |
| MACD | -0.48 | 1.49 |
| Stochastic Oscillator | 4.01 | 96.72 |
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
Atlanticus Holdings Corp is a financial technology company powering more inclusive financial solutions for Everyday Americans. It provides technology and other support services to lenders who offer an array of financial products and services to consumers. The company's products and services are reported through two reportable segments. Credit as a Service (CaaS) offers products including private label credit cards using the Fortiva and Curae brand names as well as merchant-associated brands and Auto Finance provides purchase and/or service loans secured by automobiles from or for, and also provides floor-plan financing for, a pre-qualified network of independent automotive dealers and automotive finance companies in the buy-here, pay-here used car business.